Structure Therapeutics Correlations

GPCR Stock

39.64 5.22 15.17%

The current 90-days correlation between Structure Therapeutics and Day One Biopharmaceuticals is 0.07 (i.e., Significant diversification). The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Structure Therapeutics Correlation With Market

Average diversification

The correlation between Structure Therapeutics America and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Moving together with Structure Stock

0.82	ENTO	Entero Therapeutics, Symbol Change	Pair Corr
0.63	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr

Moving against Structure Stock

0.6	XOM	Exxon Mobil Corp Fiscal Year End 7th of February 2025	Pair Corr
0.58	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.56	KO	Coca Cola Fiscal Year End 11th of February 2025	Pair Corr
0.48	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.39	FSTF	First State Financial	Pair Corr
0.37	VZ	Verizon Communications Aggressive Push	Pair Corr
0.33	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.31	PG	Procter Gamble	Pair Corr

Related Correlations Analysis

	DAWN	XFOR	INZY	ABOS	MREO	TERN	AMLX	ELDN	HOOK	BMEA
DAWN		-0.22	0.7	0.55	0.23	0.61	0.4	0.12	-0.17	0.09	DAWN
XFOR	-0.22		0.07	0.11	-0.1	0.09	-0.39	0.47	0.79	-0.22	XFOR
INZY	0.7	0.07		0.78	0.56	0.67	0.48	0.56	-0.02	0.44	INZY
ABOS	0.55	0.11	0.78		0.25	0.42	0.18	0.7	0.03	0.12	ABOS
MREO	0.23	-0.1	0.56	0.25		0.49	0.67	0.35	-0.39	0.87	MREO
TERN	0.61	0.09	0.67	0.42	0.49		0.56	0.22	0.08	0.32	TERN
AMLX	0.4	-0.39	0.48	0.18	0.67	0.56		0.0	-0.53	0.67	AMLX
ELDN	0.12	0.47	0.56	0.7	0.35	0.22	0.0		0.27	0.2	ELDN
HOOK	-0.17	0.79	-0.02	0.03	-0.39	0.08	-0.53	0.27		-0.53	HOOK
BMEA	0.09	-0.22	0.44	0.12	0.87	0.32	0.67	0.2	-0.53		BMEA
	DAWN	XFOR	INZY	ABOS	MREO	TERN	AMLX	ELDN	HOOK	BMEA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BMEA	+ 0.87	MREO
HOOK	+ 0.79	XFOR
ABOS	+ 0.78	INZY
INZY	+ 0.7	DAWN
ELDN	+ 0.7	ABOS
TERN	+ 0.67	INZY

High negative correlations

BMEA	- 0.53	HOOK
HOOK	- 0.53	AMLX
HOOK	- 0.39	MREO
AMLX	- 0.39	XFOR
BMEA	- 0.22	XFOR
XFOR	- 0.22	DAWN

Risk-Adjusted Indicators

There is a big difference between Structure Stock performing well and Structure Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Structure Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DAWN	2.35	0.10	0.04	0.16	2.38	(2.87)	6.11	(4.28)	17.10
XFOR	4.10	(0.53)	0.00	(0.17)	0.00	0.00	5.71	(11.54)	38.71
INZY	2.47	0.03	0.04	0.08	3.31	(2.64)	5.93	(6.72)	18.79
ABOS	4.13	(0.19)	(0.01)	0.01	4.50	(4.92)	9.91	(7.43)	24.99
MREO	2.77	0.44	0.13	0.48	2.99	(3.21)	6.52	(5.53)	15.72
TERN	4.49	0.66	0.16	0.47	4.10	(5.38)	11.63	(7.55)	24.10
AMLX	3.51	0.56	0.17	0.43	2.94	(4.80)	7.88	(5.26)	35.62
ELDN	2.85	(0.10)	0.00	(0.13)	0.00	0.00	6.72	(5.96)	19.36
HOOK	3.77	(0.77)	0.00	(0.18)	0.00	0.00	9.64	(8.50)	21.13
BMEA	4.14	0.97	0.22	0.79	3.92	(4.88)	10.17	(6.13)	40.07

Structure Therapeutics Corporate Management

Lani Ibarra	Senior Operations	Profile
Hui Lei	Senior Chemistry	Profile
Xichen Lin	Chief Officer	Profile
Yingli Ma	Chief Officer	Profile
Fang Zhang	Executive Biology	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC